The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care

[1]  R. Schilsky,et al.  Status Update on Data Required to Build a Learning Health System. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  D. Klonoff.  The New FDA Real-World Evidence Program to Support Development of Drugs and Biologics , 2020, Journal of diabetes science and technology.

[3]  M. Taphoorn,et al.  Current state of quality of life and patient-reported outcomes research. , 2019, European journal of cancer.

[4]  E. Dekker,et al.  Colorectal cancer , 2019, The Lancet.

[5]  Charles R. Thomas,et al.  Factors Associated With Age Disparities Among Cancer Clinical Trial Participants. , 2019, JAMA oncology.

[6]  E. Basch,et al.  Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes , 2019, Nature Reviews Drug Discovery.

[7]  W. Mackillop,et al.  Real-world data: towards achieving the achievable in cancer care , 2019, Nature Reviews Clinical Oncology.

[8]  Karl Broich,et al.  Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals? , 2018, Clinical pharmacology and therapeutics.

[9]  Jacqueline Corrigan-Curay,et al.  Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness. , 2018, JAMA.

[10]  H. Woodrow,et al.  : A Review of the , 2018 .

[11]  J. Temel,et al.  Harnessing the Power of Patient-Reported Outcomes in Oncology , 2018, Clinical Cancer Research.

[12]  S. Khozin,et al.  Real-world Data for Clinical Evidence Generation in Oncology. , 2017, Journal of the National Cancer Institute.

[13]  S. Kopetz,et al.  Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[14]  R. Califf,et al.  Real-World Evidence - What Is It and What Can It Tell Us? , 2016, The New England journal of medicine.

[15]  C. Tournigand,et al.  Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  E. Kuipers,et al.  Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research , 2016, Acta oncologica.

[17]  J Ricke,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  Ahmedin Jemal,et al.  Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.

[19]  R. Simon,et al.  The role of nonrandomized trials in the evaluation of oncology drugs , 2015, Clinical pharmacology and therapeutics.

[20]  J A Cook,et al.  The rise of big clinical databases , 2015, The British journal of surgery.

[21]  Ulrich Keilholz,et al.  The combinatorial complexity of cancer precision medicine , 2014, Oncoscience.

[22]  R. Labianca,et al.  Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[24]  Jon Nicholl,et al.  Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design , 2010, BMJ : British Medical Journal.

[25]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[26]  Peter C. Austin,et al.  Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research , 2009, Commun. Stat. Simul. Comput..

[27]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[28]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[29]  D. Hosmer,et al.  A comparison of goodness-of-fit tests for the logistic regression model. , 1997, Statistics in medicine.

[30]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[31]  J A Knottnerus,et al.  Completeness of cancer registration in Limburg, The Netherlands. , 1993, International journal of epidemiology.

[32]  Jacob Cohen,et al.  The statistical power of abnormal-social psychological research: a review. , 1962, Journal of abnormal and social psychology.

[33]  S. Pocock,et al.  Guidelines for Reporting Observational Studies , 2007 .

[34]  Stanley Lemeshow,et al.  Applied Logistic Regression, Second Edition , 1989 .

[35]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.